Impact of Exercise on the Metabolic Consequences of Overeating
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Healthy
- Sponsor
- University of Michigan
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Oral Glucose Tolerance
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The primary purpose of this study is to examine the effects of 1-week of overeating on important clinical metabolic health outcomes (e.g., glucose tolerance, blood lipid profile, and blood pressure) and factors regulating the structure and metabolic function of fat tissue. This study will determine how regular exercise during this overeating period impacts these responses.
Detailed Description
If subjects are eligible and decide to participate, they will take part in two identical study trials. One is scheduled before and the other is scheduled after 1 week of overeating controlled by the study team. Subjects who exercise regularly will be instructed to exercise the day before their first study trial - and they will be required to exercise during 6 of the 7 days of the overeating period (including the day before their second study trial). Subjects who do not regularly exercise (no planned physical activity) will remain inactive until the completion of both study trials. Before each study trial If a subject is a regular exerciser, they will be asked to come to the Substrate Metabolism Laboratory in the afternoon before each of the 2 study trials to exercise in the lab for 45 min at a moderate intensity. The evening before the study trial, all subjects will need to eat a standardized dinner meal and snack. They must eat the meal and snack at specific times as indicated by the research staff. After eating the snack, subjects will need to fast (no food or beverages - besides water) overnight. During each study trial Subjects will arrive at the Substrate Metabolism Laboratory at 7:00AM and will rest quietly for approximately 30 min. After which, the study team will measure their resting blood pressure and their resting metabolic rate. An intravenous catheter (IV) will then be placed in a vein of the subject's hand or forearm for blood sampling. The research team will then collect a small sample of fat tissue in the subject's abdomen with a needle. Next, subjects will drink a sweet sugar solution for an Oral Glucose Tolerance Test (OGTT) and the research team will collect blood samples every 15 min for 3 hours. After this 3 hour test, the IV catheter will be removed and subjects will be provided breakfast and discharged.
Investigators
Jeffrey F Horowitz
Professor, Movement Science and Director, Substrate Metabolism Laboratory
University of Michigan
Eligibility Criteria
Inclusion Criteria
- •Age: 18-40
- •Body Mass Index: 20-30 kg/m2
- •Exercise group: (≥5 days/wk of aerobic exercise; 30-60min/session at moderate and vigorous intensities)
- •No Exercise group: no regularly planned exercise/physical activity
- •Women must have regularly occurring menses and must be premenopausal
Exclusion Criteria
- •Pregnant or lactating
- •Blood pressure \> 140/90 mm Hg
- •Evidence/history of cardiovascular or metabolic disease
- •Medications known to affect lipid or glucose metabolism
- •Tobacco or electronic cigarette user
Outcomes
Primary Outcomes
Oral Glucose Tolerance
Time Frame: up to 1 week
An index of insulin sensitivity will be measured using the plasma insulin and glucose concentrations during the 3h OGTT
Secondary Outcomes
- Resting Metabolic Rate(baseline and 1 week)
- Total Cholesterol(baseline and 1 week)
- PPARg mRNA expression(baseline and 1 week)